Evidence map›Paper›PMID 32868489›Full record

ArticleMolecules and cells2020

LncRNA

Weimin Wang, Feifei Wu, Ping Ma, Silin Gan, Xue Li, Li Chen, Ling Sun, Hui Sun, Zhongxing Jiang, Feng Guo

Open access · greenAbstract read
In one paragraph

Article in Molecules and cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Targeting the lncRNA DUXAP8/miR-29a/Frontiers in oncology · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Weimin WangDepartment of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 410052, China.ORCID https://orcid.org/0000-0003-2860-6090
Feifei WuDepartment of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 410052, China.ORCID https://orcid.org/0000-0003-1384-3624
Ping MaDepartment of Hematology/Oncology, Children's Hospital Affiliated of Zhengzhou University, Zhengzhou 410052, China.ORCID https://orcid.org/0000-0001-6241-336X
Silin GanDepartment of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 410052, China.ORCID https://orcid.org/0000-0002-4489-9121
Xue LiDepartment of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 410052, China.ORCID https://orcid.org/0000-0003-2452-6106
Li ChenDepartment of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 410052, China.ORCID https://orcid.org/0000-0002-7576-0528
Ling SunDepartment of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 410052, China.ORCID https://orcid.org/0000-0002-4553-9750
Hui SunDepartment of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 410052, China.ORCID https://orcid.org/0000-0002-0500-2975
Zhongxing JiangDepartment of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 410052, China.ORCID https://orcid.org/0000-0002-0277-4574
Feng GuoDepartment of Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 410052, China.ORCID https://orcid.org/0000-0001-5096-2142
First Affiliated Hospital of Zhengzhou University · CNZhengzhou Children's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The imbalance between the proliferation and apoptosis of B-cell precursors is an important contributor to the pathogenesis of B-cell precursor acute lymphoblastic leukemia (BCP-ALL), while its specific regulatory mechanism remains perplexing. This study aimed to expound the underlying mechanism of the proliferation and apoptosis of BCP-ALL cells from the perspective of non-coding RNA. In this study, long non-coding RNA colorectal neoplasia differentially expressed (LncRNA

Indexed as

AnimalsCase-Control StudiesCell Line, TumorCell ProliferationCyclic AMP Response Element-Binding ProteinDisease ProgressionGene Knockdown TechniquesHeterograftsHumansMiceMice, Inbred NODMice, SCIDMicroRNAsPrecursor Cell Lymphoblastic Leukemia-LymphomaRNA, Long NoncodingSignal TransductionCREB1 protein, humanCRNDE RNA, humanCyclic AMP Response Element-Binding ProteinMicroRNAsMIRN345 microRNA, humanRNA, Long NoncodingB-cell precursor acute lymphoblastic leukemiacyclic AMP-binding proteinlong non-coding RNA colorectal neoplasia differentially expressedmiR-345-5p

Identifiers

PMID32868489
PMCPMC7468588
OpenAlexW3082893354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.